Utah Kidney Research Institute

Salt Lake City, Utah 84115

3 studies enrolling now · 13 studies all time

What they study most

ADPKD, Alport Syndrome, Atherosclerotic Cardiovascular Disease (ASCVD), Autosomal Dominant Polycystic Kidney, Chronic Kidney Disease, Chronic Kidney Disease (CKD), Diabetes Complications, Diabetes Mellitus, Diabetic Nephropathies, Endocrine System Diseases, FSGS, Focal Segmental Glomerulosclerosis

Studies at this site

• A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS) — Recruiting now
• A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression — Recruiting now
• A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB — Recruiting now
• A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease — Running, not enrolling
• The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) — Running, not enrolling
• Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN) — Running, not enrolling
• A Study of CCX140-B in Subjects With Primary FSGS and Nephrotic Syndrome — Stopped early
• A Study of CCX140-B in Subjects With FSGS — Completed
• Efficacy and Safety of Lixivaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease — Stopped early
• A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease — Stopped early
• TruGraf® Long-term Clinical Outcomes Study — Status unconfirmed
• A Study of RG-012 in Subjects With Alport Syndrome — Completed